Selective depletion strategies in allogeneic stem cell transplantation.
about
Cancer vaccines and T cell therapyQuality assessment of cellular therapies: the emerging role of molecular assays.Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignanciesSelective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantationReconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.T cell therapy in allogeneic stem cell transplantation.Prophylaxis of acute GVHD: manipulate the graft or the environment?Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities.Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation.Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host disease.The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond."No donor"? Consider a haploidentical transplantImmunotherapy for viral and fungal infections.Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia.Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis.
P2860
Q26995638-356BE70C-4979-415B-8357-61A4C49A105FQ34316777-685E7079-807F-486D-A847-F92C3032F68AQ35094029-42D3D933-B81F-477B-8176-597810A29042Q35230703-DEF71F2F-5B6A-4FBD-B3A0-E1A0BBD2ED4AQ35231607-83C9E421-0401-4A5C-871C-DFEF30BFD88CQ35847930-B078A561-1A43-4DF1-A250-C4DB50275FFEQ35989486-1EBB186A-1481-4BFE-B501-9B64DCB180B0Q36528822-B3425204-B185-44C0-9CE6-F3B0670BB212Q36662079-B65EB774-B089-4125-AAF9-941C3A306BB5Q37045973-163F0E0D-86BA-46A9-BC36-6A25F2B6247CQ37173456-91E6135F-D05B-4A9D-BE34-6781E6C75CDDQ37193866-C59B661C-1067-4BBF-A82F-B2A506A22D32Q37721898-0253A27A-0606-4FFB-B624-2177371ECBF8Q38003477-018E8BD9-2767-41B9-BF50-B301BAD28A1DQ38216836-D08A1AA7-1A7B-480B-B4B7-0A60F272F6C9Q38259420-A9D90105-976D-4CDE-AB35-846D25BE757AQ38514499-C2B92067-1F83-4D4A-AC11-415A56CE7474Q40657274-76D3D6A9-95B7-4940-8EF5-89101BC3E4F3Q42277574-2A523EC6-3ABA-4625-98FB-AE282A71F563
P2860
Selective depletion strategies in allogeneic stem cell transplantation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Selective depletion strategies in allogeneic stem cell transplantation.
@ast
Selective depletion strategies in allogeneic stem cell transplantation.
@en
type
label
Selective depletion strategies in allogeneic stem cell transplantation.
@ast
Selective depletion strategies in allogeneic stem cell transplantation.
@en
prefLabel
Selective depletion strategies in allogeneic stem cell transplantation.
@ast
Selective depletion strategies in allogeneic stem cell transplantation.
@en
P2093
P1433
P1476
Selective depletion strategies in allogeneic stem cell transplantation.
@en
P2093
P304
P356
10.1080/14653240510018172
P577
2005-01-01T00:00:00Z